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The interleukin-6 (IL-6) is a well-known inflammatory cytokine with pleiotropic action throughout the body.   
Lately, several studies have reported an IL-6 METABOLIC ROLE suggesting that this cytokine: 
1.  Can directly act on its membrane receptor (IL-6Rα), extensively distributed in different hypothalamus sites, 
regulating fat mass. 
2.  Mediates the expression of  some neuropeptides involved in energy homeostasis in a GENDER-DEPENDENT-
MANNER. 
3.  Leads to body weight decrease mainly through ENERGY EXPENDITURE, rather than controlling food-intake. 
Since IL-6 mechanism of  action in the central nervous system is currently unclear, much more research on this matter is required 
in order to provide NOVEL TREATMENT TARGETS for some diseases with a remarkable impact on population, as it is OBESITY. 
 
 
 
 
 
 
 
 
The discussion carried out in this review, 
about the IL-6 role in the energy balance, 
was basically based on:  
1.  Bibliographic revision: 51 original and 
review articles read, 22 CITED.  
2.  Online databases: mainly PUBMED. 
3.  Scientific journals of  high impact as: 
Journal of  Neuroendocrinology. 
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Fig. 1. a) Changes in body weight during two weeks of  i.c.v treatment with 
IL-6 in comparison with saline. 
b) IL-6 -/- (IL-6-KO) mice developed mature-onset obesity.
Results from Wallenius, K. et al., and Wallenius, V.  et al. see 
References1,2.

Fig. 2. a) Body weight gain in IL-6-KO and floxed mice fed the 
control diet and the HFD with sex-specific differences.  
b) Gender-dependent quantification for the main neuropeptides 
involved in food intake and energy expenditure in specific 
hypothalamic nuclei: corticotrophin-releasing hormone (CRH), prepro-
orexin (ppOx), agouti-related peptide (AgRP), neuropeptide Y (NPY) 
and pro-opiomelanocortin (POMC).  
Results from	  B. Ferrer et al., see References3.
 
Control IL-6-/-
a) b) 
The general believed of  obesity as  PRO-
INFLAMMATORY STATE, involving high IL-6 
levels, could seem inconsistent with results 
shown in  a) and b). However, these results 
demonstrate a metabolic role of  the IL-6 in 
the energ y ba lance regulat ion (see 
Conclusions). 
  a) Intra-cerebro-ventricular 
(i.c.v) administration decreases 
body weight. 
b) Mice lacking the IL-6 gene 
(IL-6-KO) developed later-onset 
obesity. 
Conclusions
Contracting muscle is considered an 
IMPORTANT SOURCE of  IL-6 since this 
cytokine is over-expressed during exercise.  
a) b) 
Muscle IL-6 has a role in a sex-specific 
fashion decreasing body weight, as shown in 
Fig.2. a. 
Adittionally, neuropeptides related with fat mass 
regulation seemed to be mediated by muscle IL-6, as 
shown in Fig.2. b 
 
 
1.  Since the adipose-derived hormone leptin 
correlates with adipose tissue mass during 
obesity, the IL-6 might correlate with the pro-
inflammatory state of  obese patients as well as 
with their adipose tissue mass in a similar way 
as leptin. Thus, it is suggested that IL-6 could 
signal the CNS to regulate fat mass in 
analogous form as leptin does. 
2.  The IL-6 influence on homeostasis is exerted 
via some energy balance-related nuclei and 
neuropeptides in the hypothalamus and 
hindbrain, regulating body weight mainly 
through increased energy expenditure rather 
than controlling food intake. 
3.  Deletion of  cell-specific IL-6 seems to have 
similar repercussions on energy balance. 
Development of  gender-cell-specific IL-6 
knockout mice is, indeed, an efficient tool 
suggested for future studies. 
(see Conclusions). 
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IL-6 and IL-1 Fig. 3. a) Cells with co-localised IL-6Rα-and NPY in the ARC. 
Hypothalamic NPY, AgRP and POMC mRNA 
levels in IL-1 receptor type I deficient 
(IL-1R1-/-) mice (b) and IL-6 deficient 
(IL-6-/-) mice(c) .  
Results from Schéle et al., see References4. 
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Graphic 1. Rodent-vs-Human: Different 
central IL-6Rα distribution. Main areas where the 
IL-6 membrane receptor was found by current 
studies and principal neuropeptides which 
expression was altered by IL-6: lateral 
hypothalamic area (LHA), paraventricular nucleus 
(PVN), arcuate nucleus (ARC) and melanin-
concentrating hormone (MCH).  
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²  COOPERATIVE FUNCTION of  IL-6 with 
IL-1 appears to be important for 
obesity development. 
²  I n f l u e n c e o n f a t r e g u l a t i n g 
neuropeptides was observed in IL-6 
and IL-1R1-KO mice, as shown in  
Fig. 3. b and c. 
²  Both cytokines might exert anti-
obesity effect acting on the GLP-1 
receptor in the HINDBRAIND.  
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Image modified from Schéle et al.. 
